196 related articles for article (PubMed ID: 36883690)
1. Estrogen receptors as potential therapeutic target in endometrial cancer.
Guha P; Sen K; Chowdhury P; Mukherjee D
J Recept Signal Transduct Res; 2023 Feb; 43(1):19-26. PubMed ID: 36883690
[TBL] [Abstract][Full Text] [Related]
2. The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer.
Hojnik M; Sinreih M; Anko M; Hevir-Kene N; Knific T; Pirš B; Grazio SF; Rižner TL
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769338
[TBL] [Abstract][Full Text] [Related]
3. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor Function: Impact on the Human Endometrium.
Yu K; Huang ZY; Xu XL; Li J; Fu XW; Deng SL
Front Endocrinol (Lausanne); 2022; 13():827724. PubMed ID: 35295981
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.
Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S
Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
7. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.
Lin BC; Suzawa M; Blind RD; Tobias SC; Bulun SE; Scanlan TS; Ingraham HA
Cancer Res; 2009 Jul; 69(13):5415-23. PubMed ID: 19549922
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
9. GPER and ERα expression in abnormal endometrial proliferations.
Tica AA; Tica OS; Georgescu CV; Pirici D; Bogdan M; Ciurea T; Mogoantă SŞ; Georgescu CC; Comănescu AC; Bălşeanu TA; Ciurea RN; Osiac E; Buga AM; Ciurea ME
Rom J Morphol Embryol; 2016; 57(2):413-8. PubMed ID: 27516013
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells.
Torres-López L; Maycotte P; Liñán-Rico A; Liñán-Rico L; Donis-Maturano L; Delgado-Enciso I; Meza-Robles C; Vásquez-Jiménez C; Hernández-Cruz A; Dobrovinskaya O
J Leukoc Biol; 2019 May; 105(5):983-998. PubMed ID: 30645008
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium.
Plante BJ; Lessey BA; Taylor RN; Wang W; Bagchi MK; Yuan L; Scotchie J; Fritz MA; Young SL
Reprod Sci; 2012 Jul; 19(7):684-93. PubMed ID: 22378861
[TBL] [Abstract][Full Text] [Related]
12. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
[TBL] [Abstract][Full Text] [Related]
14. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
[TBL] [Abstract][Full Text] [Related]
15. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
Li Y; Jia Y; Bian Y; Tong H; Qu J; Wang K; Wan XP
Cell Commun Signal; 2019 Mar; 17(1):22. PubMed ID: 30836961
[TBL] [Abstract][Full Text] [Related]
16. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.
Revankar CM; Bologa CG; Pepermans RA; Sharma G; Petrie WK; Alcon SN; Field AS; Ramesh C; Parker MA; Savchuk NP; Sklar LA; Hathaway HJ; Arterburn JB; Oprea TI; Prossnitz ER
Cell Chem Biol; 2019 Dec; 26(12):1692-1702.e5. PubMed ID: 31706983
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
Zhang H; Wang X; Chen Z; Wang W
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889
[TBL] [Abstract][Full Text] [Related]
18. [Effect of GPER on the activation of PI3K/Akt induced by 17β-estradiol in endometrial carcinoma cells].
Zhang YC; Guo RX; Ge X; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):292-6. PubMed ID: 22781117
[TBL] [Abstract][Full Text] [Related]
19. The Estrogen Receptors: An Overview from Different Perspectives.
Eyster KM
Methods Mol Biol; 2016; 1366():1-10. PubMed ID: 26585122
[TBL] [Abstract][Full Text] [Related]
20. High affinity nuclear and nongenomic estradiol binding sites in the human and mouse lens.
Kirker MR; Gallagher KM; Witt-Enderby PA; Davis VL
Exp Eye Res; 2013 Jul; 112():1-9. PubMed ID: 23597597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
